Always speak with a qualified healthcare provider before starting any new supplement, especially if you have a medical condition, are pregnant or nursing, or are taking prescription medication
Your consent to this Privacy Policy followed by Your submission of such information represents Your agreement to that transfer
As part of our Carbohydrate Resilience (CarbR) test, patients wear a CGM for 1014 days while logging their meals
Jackson, Dayan de Fontgalland, Philippa Rabbitt, Paul Hollington, Luigi Sposato, Steven Due, David A
Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for 4 weeks (a non-therapeutic initiation dose to improve tolerability), then increased every 4 weeks to reach a therapeutic dose of 5-15 mg weekly based on response and tolerability